firstline pharma ltd
firstline pharma ltd Company Information
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
ravalco house cleveland way, hemel hempstead industrial estat, hemel hempstead, HP2 7DL
Website
www.nashchemists.comfirstline pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of FIRSTLINE PHARMA LTD at £1m based on a Turnover of £2.1m and 0.48x industry multiple (adjusted for size and gross margin).
firstline pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of FIRSTLINE PHARMA LTD at £279.7k based on an EBITDA of £58.2k and a 4.81x industry multiple (adjusted for size and gross margin).
firstline pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of FIRSTLINE PHARMA LTD at £6.3m based on Net Assets of £3.3m and 1.91x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Firstline Pharma Ltd Overview
Firstline Pharma Ltd is a live company located in hemel hempstead, HP2 7DL with a Companies House number of 08065603. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 2012, it's largest shareholder is ravalco ltd with a 100% stake. Firstline Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £2.1m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Firstline Pharma Ltd Health Check
Pomanda's financial health check has awarded Firstline Pharma Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
6 Weak
Size
annual sales of £2.1m, make it smaller than the average company (£24.8m)
- Firstline Pharma Ltd
£24.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -19%, show it is growing at a slower rate (5.3%)
- Firstline Pharma Ltd
5.3% - Industry AVG
Production
with a gross margin of 27.4%, this company has a comparable cost of product (27.4%)
- Firstline Pharma Ltd
27.4% - Industry AVG
Profitability
an operating margin of 0.8% make it less profitable than the average company (4.1%)
- Firstline Pharma Ltd
4.1% - Industry AVG
Employees
with 11 employees, this is below the industry average (33)
11 - Firstline Pharma Ltd
33 - Industry AVG
Pay Structure
on an average salary of £77.9k, the company has an equivalent pay structure (£77.9k)
- Firstline Pharma Ltd
£77.9k - Industry AVG
Efficiency
resulting in sales per employee of £192.9k, this is less efficient (£678.6k)
- Firstline Pharma Ltd
£678.6k - Industry AVG
Debtor Days
it gets paid by customers after 14 days, this is earlier than average (58 days)
- Firstline Pharma Ltd
58 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is quicker than average (31 days)
- Firstline Pharma Ltd
31 days - Industry AVG
Stock Days
it holds stock equivalent to 37 days, this is less than average (57 days)
- Firstline Pharma Ltd
57 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 201 weeks, this is more cash available to meet short term requirements (10 weeks)
201 weeks - Firstline Pharma Ltd
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 9.7%, this is a lower level of debt than the average (58.2%)
9.7% - Firstline Pharma Ltd
58.2% - Industry AVG
FIRSTLINE PHARMA LTD financials
Firstline Pharma Ltd's latest turnover from August 2023 is estimated at £2.1 million and the company has net assets of £3.3 million. According to their latest financial statements, Firstline Pharma Ltd has 11 employees and maintains cash reserves of £849.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 11 | 11 | 11 | 11 | 10 | 7 | 7 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 405,917 | 429,739 | 476,116 | 132,072 | 65,080 | 66,829 | 15,141 | 17,257 | 18,740 | 20,089 | 21,287 |
| Intangible Assets | 54,826 | 82,238 | 109,650 | 137,062 | 164,474 | 191,886 | 219,298 | 246,710 | |||
| Investments & Other | |||||||||||
| Debtors (Due After 1 year) | |||||||||||
| Total Fixed Assets | 405,917 | 429,739 | 476,116 | 186,898 | 147,318 | 176,479 | 152,203 | 181,731 | 210,626 | 239,387 | 267,997 |
| Stock & work in progress | 159,544 | 205,574 | 319,807 | 151,926 | 665,227 | 30,193 | 27,382 | 30,995 | 31,867 | 28,068 | 40,758 |
| Trade Debtors | 85,907 | 236,715 | 51,969 | 529,693 | 93,815 | 288,662 | 80,811 | 50,675 | 77,974 | 116,905 | 122,947 |
| Group Debtors | 1,834,187 | 352,201 | 288,607 | 123,889 | 291,722 | 234,820 | 220,866 | 262,270 | |||
| Misc Debtors | 299,403 | 323,291 | 263,056 | 376,951 | 342,569 | 55,723 | 36,124 | 10,477 | |||
| Cash | 849,293 | 2,266,546 | 2,572,122 | 3,986,595 | 2,318,404 | 1,611,835 | 273,370 | 14,344 | 42,330 | 38,944 | 205,567 |
| misc current assets | 2,964 | ||||||||||
| total current assets | 3,228,334 | 3,384,327 | 3,495,561 | 5,169,054 | 3,711,737 | 2,221,233 | 638,553 | 371,725 | 152,171 | 183,917 | 369,272 |
| total assets | 3,634,251 | 3,814,066 | 3,971,677 | 5,355,952 | 3,859,055 | 2,397,712 | 790,756 | 553,456 | 362,797 | 423,304 | 637,269 |
| Bank overdraft | |||||||||||
| Bank loan | 6,617 | 9,398 | 7,832 | 61,625 | |||||||
| Trade Creditors | 100,501 | 249,938 | 85,809 | 693,028 | 847,670 | 283,337 | 246,640 | 84,193 | 157,492 | 179,563 | 341,022 |
| Group/Directors Accounts | 194,740 | 159,359 | 834,311 | 406,317 | |||||||
| other short term finances | 930,330 | 37,930 | 103,534 | ||||||||
| hp & lease commitments | |||||||||||
| other current liabilities | 111,793 | 6,944 | 43,805 | 192,706 | 368,493 | 400,049 | 27,397 | 4,143 | |||
| total current liabilities | 218,911 | 461,020 | 296,805 | 1,720,045 | 1,622,480 | 1,613,716 | 373,592 | 191,870 | 157,492 | 179,563 | 341,022 |
| loans | 36,559 | 39,221 | 42,168 | 326,084 | 380,302 | ||||||
| hp & lease commitments | |||||||||||
| Accruals and Deferred Income | |||||||||||
| other liabilities | 205,162 | 240,108 | 271,924 | ||||||||
| provisions | 96,931 | 101,893 | 112,359 | 18,913 | 4,319 | 3,136 | 2,574 | ||||
| total long term liabilities | 133,490 | 141,114 | 154,527 | 18,913 | 4,319 | 3,136 | 328,658 | 380,302 | 205,162 | 240,108 | 271,924 |
| total liabilities | 352,401 | 602,134 | 451,332 | 1,738,958 | 1,626,799 | 1,616,852 | 702,250 | 572,172 | 362,654 | 419,671 | 612,946 |
| net assets | 3,281,850 | 3,211,932 | 3,520,345 | 3,616,994 | 2,232,256 | 780,860 | 88,506 | -18,716 | 143 | 3,633 | 24,323 |
| total shareholders funds | 3,281,850 | 3,211,932 | 3,520,345 | 3,616,994 | 2,232,256 | 780,860 | 88,506 | -18,716 | 143 | 3,633 | 24,323 |
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 41,614 | 46,715 | 29,625 | 13,003 | 7,312 | 2,866 | 3,155 | 3,650 | 4,003 | 3,928 | |
| Amortisation | 15,990 | 27,412 | 27,412 | 27,412 | 27,412 | 27,412 | 27,412 | 27,412 | |||
| Tax | |||||||||||
| Stock | -46,030 | -114,233 | 167,881 | -513,301 | 635,034 | 2,811 | -3,613 | -872 | 3,799 | -12,690 | 40,758 |
| Debtors | 1,307,290 | 308,575 | -426,901 | 302,427 | 148,901 | 241,404 | 14,379 | 245,448 | -38,931 | -6,042 | 122,947 |
| Creditors | -149,437 | 164,129 | -607,219 | -154,642 | 564,333 | 36,697 | 162,447 | -73,299 | -22,071 | -161,459 | 341,022 |
| Accruals and Deferred Income | 104,849 | -36,861 | -148,901 | -175,787 | -31,556 | 372,652 | 23,254 | 4,143 | |||
| Deferred Taxes & Provisions | -4,962 | -10,466 | 93,446 | 14,594 | 1,183 | 562 | 2,574 | ||||
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | |||||||||||
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | -2,781 | 1,566 | 7,832 | -61,625 | 61,625 | ||||||
| Group/Directors Accounts | -194,740 | 35,381 | -674,952 | 427,994 | 406,317 | ||||||
| Other Short Term Loans | -930,330 | 892,400 | -65,604 | 103,534 | |||||||
| Long term loans | -2,662 | -2,947 | 42,168 | -326,084 | -54,218 | 380,302 | |||||
| Hire Purchase and Lease Commitments | |||||||||||
| other long term liabilities | -205,162 | -34,946 | -31,816 | 271,924 | |||||||
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | -1,417,253 | -305,576 | -1,414,473 | 1,668,191 | 706,569 | 1,338,465 | 259,026 | -27,986 | 3,386 | -166,623 | 205,567 |
| overdraft | |||||||||||
| change in cash | -1,417,253 | -305,576 | -1,414,473 | 1,668,191 | 706,569 | 1,338,465 | 259,026 | -27,986 | 3,386 | -166,623 | 205,567 |
firstline pharma ltd Credit Report and Business Information
Firstline Pharma Ltd Competitor Analysis
Perform a competitor analysis for firstline pharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HP2 area or any other competitors across 12 key performance metrics.
firstline pharma ltd Ownership
FIRSTLINE PHARMA LTD group structure
Firstline Pharma Ltd has no subsidiary companies.
firstline pharma ltd directors
Firstline Pharma Ltd currently has 2 directors. The longest serving directors include Mr Jiten Raval (May 2012) and Ms Melissa Raval (Sep 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jiten Raval | England | 39 years | May 2012 | - | Director |
| Ms Melissa Raval | England | 41 years | Sep 2018 | - | Director |
P&L
August 2023turnover
2.1m
-22%
operating profit
16.6k
0%
gross margin
27.5%
+4.45%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2023net assets
3.3m
+0.02%
total assets
3.6m
-0.05%
cash
849.3k
-0.63%
net assets
Total assets minus all liabilities
firstline pharma ltd company details
company number
08065603
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
May 2012
age
13
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
August 2023
previous names
firstline pharmacy limited (March 2020)
accountant
HAZLEWOODS LLP
auditor
-
address
ravalco house cleveland way, hemel hempstead industrial estat, hemel hempstead, HP2 7DL
Bank
-
Legal Advisor
-
firstline pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to firstline pharma ltd.
firstline pharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for FIRSTLINE PHARMA LTD. This can take several minutes, an email will notify you when this has completed.
firstline pharma ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
